Asian press release distribution

Press Releases for Thursday, January 20, 2022

热爆NFT「MetaBunny」元兔引领潮流限量预售仅1小时炒至超过15倍 20:11 HKT/SGT

熱爆NFT「MetaBunny」元兔引領潮流限量預售僅1小時炒至超過15倍 20:10 HKT/SGT

Realbox launches one of world's first blockchain-based real estate tokenization platforms 20:00 HKT/SGT

三菱重工と三菱ロジスネクスト、シグマシンクスによる倉庫物流の知能化・自動化プロジェクトが始動 15:30 HKT/SGT

Slime Royale Announces to Receive Strategic Investment and Incubation Support from Appota Group 14:00 HKT/SGT

Hitachi Rail Awarded Contract to Operate and Maintain Princess Noura Bint Abdul Rahman University Autonomous System in Riyadh, Saudi Arabia 13:14 HKT/SGT

CheckDot Announces the Launch of Its Platform Which Will Save Crypto Industry 13:00 HKT/SGT

日立建機と日立、日立建機のDX加速に向け、OT・ITデータ利活用のプラットフォームを構築 13:00 HKT/SGT

Honda、ソフトウェア技術の開発強化に向け、米国Helm.ai社に出資 12:30 HKT/SGT

Honda Invests in U.S.-based Helm.ai to Strengthen its Software Technology Development 12:04 HKT/SGT

インタービュー：2022年のEmurgo、カルダノ(ADA)について知っておくべきこと 12:00 HKT/SGT

2022년 Cardano(ADA)에 대해 알아야 할 사항 11:00 HKT/SGT

Interview: What You Need to Know about Cardano (ADA) in 2022 11:00 HKT/SGT

昭和電工、液状プライマーを用いた異種材料接合技術に関する基本特許網を構築 11:00 HKT/SGT

NEC、小規模ネットワークに適したローカル5G基地局UNIVERGE RV1000シリーズ2機種を販売開始 10:00 HKT/SGT

NexBloc and Arcade Network Partner to Bring Blockchain Domains to Gaming in the Metaverse 09:28 HKT/SGT

エーザイ、｢レンビマ(R)｣と｢キイトルーダ(R)｣の併用療法について進行性子宮内膜がんを対象とした臨床第III相309試験/KEYNOTE-775試験の結果がthe New England Journal of Medicineに掲載 09:00 HKT/SGT

ShibRWD ($SRWD)、BitMartへのプライマリー上場を発表 09:00 HKT/SGT

Eisai: Results From Pivotal Phase 3 Study 309/KEYNOTE-775 Trial of LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Advanced Endometrial Carcinoma 08:56 HKT/SGT

ACN Search:

CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575